Regulation and metabolic functions of mTORC1 and mTORC2

A Szwed, E Kim, E Jacinto - Physiological reviews, 2021 - journals.physiology.org
Cells metabolize nutrients for biosynthetic and bioenergetic needs to fuel growth and
proliferation. The uptake of nutrients from the environment and their intracellular metabolism …

Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy

J Kang, N Brajanovski, KT Chan, J Xuan… - Signal transduction and …, 2021 - nature.com
Ribosome biogenesis and protein synthesis are fundamental rate-limiting steps for cell
growth and proliferation. The ribosomal proteins (RPs), comprising the structural parts of the …

Integrated proteogenomic characterization of clear cell renal cell carcinoma

DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song… - Cell, 2019 - cell.com
To elucidate the deregulated functional modules that drive clear cell renal cell carcinoma
(ccRCC), we performed comprehensive genomic, epigenomic, transcriptomic, proteomic …

Ribosome biogenesis in cancer: new players and therapeutic avenues

J Pelletier, G Thomas, S Volarević - Nature Reviews Cancer, 2018 - nature.com
The ribosome is a complex molecular machine composed of numerous distinct proteins and
nucleic acids and is responsible for protein synthesis in every living cell. Ribosome …

Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis

RY Ebright, S Lee, BS Wittner, KL Niederhoffer… - Science, 2020 - science.org
Circulating tumor cells (CTCs) are shed into the bloodstream from primary tumors, but only a
small subset of these cells generates metastases. We conducted an in vivo genome-wide …

Targeting mTOR and metabolism in cancer: lessons and innovations

C Magaway, E Kim, E Jacinto - Cells, 2019 - mdpi.com
Cancer cells support their growth and proliferation by reprogramming their metabolism in
order to gain access to nutrients. Despite the heterogeneity in genetic mutations that lead to …

Targeting the RNA polymerase I transcription for cancer therapy comes of age

R Ferreira, JS Schneekloth Jr, KI Panov, KM Hannan… - Cells, 2020 - mdpi.com
Transcription of the ribosomal RNA genes (rDNA) that encode the three largest ribosomal
RNAs (rRNA), is mediated by RNA Polymerase I (Pol I) and is a key regulatory step for …

[HTML][HTML] mTOR inhibitors in cancer therapy

J Xie, X Wang, CG Proud - F1000Research, 2016 - ncbi.nlm.nih.gov
The mammalian target of rapamycin, mTOR, plays key roles in cell growth and proliferation,
acting at the catalytic subunit of two protein kinase complexes: mTOR complexes 1 and 2 …

Targeting ribosome biogenesis in cancer: lessons learned and way forward

A Zisi, J Bartek, MS Lindström - Cancers, 2022 - mdpi.com
Simple Summary Cells need to produce ribosomes to sustain continuous proliferation and
expand in numbers, a feature that is even more prominent in uncontrollably proliferating …

First-in-human RNA polymerase I transcription inhibitor CX-5461 in patients with advanced hematologic cancers: results of a phase I dose-escalation study

A Khot, N Brajanovski, DP Cameron, N Hein… - Cancer discovery, 2019 - AACR
Abstract RNA polymerase I (Pol I) transcription of ribosomal RNA genes (rDNA) is tightly
regulated downstream of oncogenic pathways, and its dysregulation is a common feature in …